Actually, when the Jefferies analyst proffered a range of $100-200M, Jay Luly responded without hesitation by saying, “North of that,” which strongly suggests that Luly has a specific number in mind. That Luly has a specific number in mind further suggests that ENTA and/or a prospective partner have given serious consideration to the design of the phase-3 trials.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.